Method Development

Right‑fit analytical methods that secure stability data and simplify validation and transfer.

Drug Manufacturing banner

Transfer‑Ready Analytical Methods

We develop product-specific methods in chemistry and microbiology.

Analytical method development at Groupe PARIMA generates fit‑for‑purpose data to support product characterization, evaluate stability behavior, and inform development decisions with confidence.  

Methods are designed with a lifecycle perspective, ensuring suitability for ongoing stability studies as well as readiness for validation and seamless analytical transfer as development progresses.

Stage Ready Method Development

We connect chemistry and microbiology with stage-appropriate execution, so your data supports decisions on development, stability, and transfer.

Card 01

Analytical Strategy Definition

We define the method’s intended use and performance targets (ATP) based on your product, matrix, and program stage, establishing clear acceptance criteria for development, validation, and transfer.

Card 02

Early Feasibility Evaluation

We assess product knowledge, available reference methods, and product behavior to confirm the approach and expected sensitivity. Early feasibility focus development on conditions that fit the product.

Card 03

Method Scouting and Optimization

We optimize existing methods by scouting standard conditions based on product properties and matrix, establishing a robust fit‑for‑purpose analytical starting point for development, validation, and transfer.

Card 04

Optimization for Validation

We refine critical method parameters to achieve consistent performance and target sensitivity. Parameters are evaluated and adjusted to ensure the method can reliably generate data under expected conditions.

Our quality by design approach strengthens method performance and supports regulatory confidence in your data.

Resources

Discover resources that help teams plan, develop, and transfer analytical methods with regulatory alignment in mind.

Groupe PARIMA
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
Topical 101: A Guide to Complex Dermatology Formulation Development
Groupe PARIMA
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
Topical 101: A Guide to Complex Dermatology Formulation Development

Contact Us

Have a project in pipeline?

Let’s discuss analytical method development and testing needs to support stability, development decisions, and stage-appropriate execution.